Neonatal mouse testis-derived multipotent germline stem cells improve the cardiac function of acute ischemic heart mouse model

Biochemical and Biophysical Research Communications

Volumn 400, Issue 1, 2010, Pages 27-33

  Iwasa, Toru ^a   Baba, Shiro ^a   Doi, Hiraku ^a   Kaichi, Shinji ^a   Yokoo, Noritaka ^a   Mima, Takahiro ^a   Kanatsu Shinohara, Mito ^a   Shinohara, Takashi ^a   Nakahata, Tatsutoshi ^a   Heike, Toshio ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cardiac regeneration therapy; Flk1; MGS

Indexed keywords

BETA GALACTOSIDASE; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GERM LINE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL; HEART VENTRICLE HYPERTROPHY; ISCHEMIC HEART DISEASE; MALE; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; ANIMAL; CELL AGING; CELL DIFFERENTIATION; CYTOLOGY; DBA MOUSE; DISEASE MODEL; ENZYMOLOGY; GERM CELL; HEART MUSCLE CELL; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; TESTIS; TRANSPLANTATION;

ANIMALS; CELL AGING; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GERM CELLS; MALE; MICE; MICE, INBRED DBA; MULTIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; TESTIS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MUS;

EID: 79957546121     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.131     Document Type: Article

References (23)

1. Etoch S.W., Koenig S.C., Laureano M.A., et al. Results after partial left ventriculectomy versus heart transplantation for idiopathic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 1999, 117(5):952-959.
2. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001, 7(4):430-436.
3. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114(6):763-776.
4. Pagani F.D., DerSimonian H., Zawadzka A., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol. 2003, 41(5):879-888.
5. Baba S., Heike T., Yoshimoto M., et al. Flk1(+) cardiac stem/progenitor cells derived from embryonic stem cells improve cardiac function in a dilated cardiomyopathy mouse model. Cardiovasc. Res. 2007, 76(1):119-131.
6. Kocher A.A., Schuster M.D., Bonaros N., et al. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J. Mol. Cell. Cardiol. 2006, 40(4):455-464.
7. Nishikawa S.I., Nishikawa S., Hirashima S., et al. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 1998, 125(9):1747-1757.
8. Iida M., Heike T., Yoshimoto M., et al. Identification of cardiac stem cells with FLK1, CD31, and VE-cadherin expression during embryonic stem cell differentiation. FASEB J. 2005, 19(3):371-378.
9. Kanatsu-Shinohara M., Inoue K., et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell 2004, 119(7):1001-1012.
10. Baba S., Heike T., Umeda K., et al. Generation of cardiac and endothelial cells from neonatal mouse testis-derived multipotent germline stem cells. Stem Cells 2007, 25(6):1375-1383.
11. Hirashima M., Kataoka H., Nishikawa S., et al. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 1999, 93(4):1253-1263.
12. Ogawa M., Kizumoto M., Nishikawa S., et al. Expression of alpha4-integrin defines the earliest precursor of hematopoietic cell lineage diverged from endothelial cells. Blood 1999, 93(4):1168-1177.
13. Minamino T., Yoshida T., Tateno K., et al. Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation 2003, 108(18):2264-2269.
14. Minamino T., Miyauchi H., Yoshida T., Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomeres in endothelial dysfunction. J. Cardiol. 2003, 41(1):39-40.
15. Chimenti C., Kajstura J., Torella D., et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ. Res. 2003, 93(7):604-613.
16. Gonzalez A., Rota M., Nurzynska D., et al. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ. Res. 2008, 102(5):597-606.
17. Chang B.D., Xuan Y., Broude E.V., et al. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 1999, 18(34):4808-4818.
18. Zhang X., Li J., Sejas D.P., Pang Q. The ATM/p53/p21 pathway influences cell fate decision between apoptosis and senescence in reoxygenated hematopoietic progenitor cells. J. Biol. Chem. 2005, 280(20):19635-19640.
19. Silva G.V., Perin E.C., Dohmann H.F., et al. Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation. Tex. Heart Inst. J. 2004, 31(3):214-219.
20. Hattan N., Kawaguchi H., Ando K., et al. Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc. Res. 2005, 65(2):334-344.
21. Laflamme M.A., Chen K.Y., Naumova A.V., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25(9):1015-1024.
22. Yamada Y., Yokoyama S., Wang X., et al. Cardiac stem cells in brown adipose tissue express CD133 and induce bone marrow nonhematopoietic cells to differentiate into cardiomyocytes. Stem Cells 2007, 25:1326-1333.
23. Schuster M.D., Kocher A.A., Seki T., et al. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am. J. Physiol. Heart Circ. Physiol. 2004, 287(2):H525-H532.